Etienne Chatelut

23PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsGene and molecular therapyClinical pharmacology and therapeuticsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 18, 2026
Does Next Generation Sequencing (NGS)-Based CYP2D6 Sequencing Improve Genotype-Phenotype Concordance in Tamoxifen-Treated Patients?

|Jun 12, 2026
Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokinetics.

|Mar 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Mar 09, 2026
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods.

Félicien Le Louedec, Laura Morvan, Loïc Mourey

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Dec 11, 2025
Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy.

Matthieu Gracia, Sabrina Marsili, Julien Vintejoux

Pageof 4

Frequent Collaborators

4 joint publications

Fabienne Thomas

4 joint publications

Scott Howard

4 joint publications

Stefan Schwartz

4 joint publications

Miriam Hwang